A company that offers a platform for digital clinical trials has settled a Federal Trade Commission complaint by agreeing not to falsely claim that it takes part in an EU-U.S. data transfer program.
Medable Inc. misrepresented in its privacy policy that it participated in the EU-U.S. Privacy Shield framework, the FTC said in a Nov. 19 statement announcing the settlement. The company started an application to the program in 2017 but didn’t finish the process, the commission said.
The action highlights the risks companies face if they misrepresent certification with Privacy Shield or similar programs. The proposed settlement brings to ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.